Results 71 to 80 of about 38,477 (196)

Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and gender

open access: yes, 2014
[[abstract]]We prospectively investigated 615,532 diabetic patients and 614,871 age-matched and sex-matched control subjects selected from National Health Insurance claims for malignant neoplasms of liver and biliary tract (International Statistical ...
Chen, Hua-Fen;Peter, Chen;Li, Chung-Yi   +1 more
core  

Mixed squamous – neuroendocrine carcinoma of the gallbladder: A case report of a rare pathological entity

open access: yesCancer Research, Statistics, and Treatment
Gallbladder cancers are the most common biliary tract malignancies in the world. Adenocarcinoma constitutes the most common histology in gallbladder cancer.
Rohik Anjum T. Siddeek   +6 more
doaj   +1 more source

Usefulness of Direct Peroral Cholangioscopy Using a Multibending Ultraslim Endoscope for the Management of Intrahepatic Bile Duct Lesions (with Videos)

open access: yesGut and Liver
Background/Aims: Peroral cholangioscopy (POC) has been used to assess intrahepatic duct (IHD) lesions but with a limited role. A new multibending (MB) ultraslim endoscope has been designed to improve POC performance.
Won Myung Lee   +8 more
doaj   +1 more source

[Surgical treatment of biliary tract neoplasms].

open access: yesWiadomosci lekarskie (Warsaw, Poland : 1960), 1998
The authors present their own experiences concerning the treatment of the 34 patients with the benign and malignant tumors of the biliary tract. In the group of patients with malignant tumors, the type and extent of the surgery were dictated by the stage of the disease.
W, Patkowski   +5 more
openaire   +1 more source

Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study

open access: yesBMC Complementary and Alternative Medicine, 2018
Background Advanced hepatobiliary cancers are highly lethal cancers that require precise prediction in clinical practice. Serum ferritin level increases in malignancy and high serum ferritin level is associated with poor survival in various cancers. This
Anna Song   +4 more
doaj   +1 more source

[Internal biliary diversions in inoperable neoplasms of the biliary tract and pancreas].

open access: yesIl Giornale di chirurgia, 1991
The authors report their experience with the treatment of mechanical jaundice in inoperable malignant neoplasms of the bile ducts and pancreas. They emphasize the importance of intrahepatic peripheral biliodigestive derivations (Soupault and Couinaud operation).
G, Giordano   +8 more
openaire   +1 more source

Correlation between overall survival and other efficacy endpoints in advanced biliary tract cancer: Literature-based analysis from 13 randomized trials of first-line chemotherapy.

open access: yes, 2014
352 Background: Chemotherapy for advanced biliary tract cancer (ABC) has progressed. Now gemcitabine plus cisplatin combination is considered the standard 1st-line treatment based on the results of many randomized studies.
Akinori Sugaya   +6 more
core   +1 more source

Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma

open access: yesRadiology Case Reports, 2019
Intraductal papillary mucinous neoplasm of the biliary tract (IPMN-B) is an increasingly recognized pathologic entity characterized by intraluminal papillary masses and increased mucin secretion, resulting in obstruction and dilation of the biliary tree.
David J. Ritchie, MD   +2 more
openaire   +3 more sources

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

open access: yesAutopsy and Case Reports, 2019
The combination of cisplatin and gemcitabine is the standard first-line treatment of metastatic biliary tract cancer (BTC) patients. The benefit of second-line chemotherapy in these patients is controversial.
Rafael Caparica   +3 more
doaj  

Durvalumab plus gemcitabine-cisplatin versus S-1 plus gemcitabine-cisplatin in advanced biliary tract cancer: a comparative study

open access: yesESMO Gastrointestinal Oncology
Background and purpose: Following the TOPAZ-1 trial, chemoimmunotherapy with durvalumab plus gemcitabine and cisplatin (GCD) became the standard first-line treatment of advanced biliary tract cancer (BTC).
T. Satake   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy